// company-profile

Avalo Therapeutics, Inc.

AVTX
ExchangeNasdaqSectorPharmaceutical PreparationsInc.DEFilings112Insiders20
// api This Avalo Therapeutics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 6 insiders purchased shares versus 4 sales. Buying was led by KAPLAN GILLA.

// 90-day insight

Over the last 90 days, Avalo Therapeutics, Inc. insiders bought $0 (11 transactions) and sold $38K (4 transactions).

  • Most active insider: Doyle Mittie with 17 transactions totaling $3.5M.
  • Largest single purchase: $985K by Doyle Mittie on May 6, 2026.
  • 83% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of Avalo Therapeutics, Inc. as of 2026-03-31

↑ increasing
Total reported AUM
$469.0M
QoQ change
+28.5%
Reporting period
2026-03-31
#1
FMR LLC
CIK 315066
$28.2M
1.9M shares
#2
Caligan Partners LP
CIK 1727492
$24.4M
1.6M shares
#3
BVF INC/IL
CIK 1056807
$24.4M
1.6M shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 10, 2026Sullivan Christopher RyanAVTX
Tax Withholding
138$13.10$2K
Jun 10, 2026Doyle MittieAVTX
Tax Withholding
1,084$13.10$14K
Jun 10, 2026VARKI PAULAVTX
Tax Withholding
1,081$13.10$14K
Jun 10, 2026Riley JenniferAVTX
Tax Withholding
588$13.10$8K
Jun 2, 2026KAPLAN GILLAAVTX
Award
20,100$0.00$0K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.